To meet the needs of the increasingly complex development and regulatory landscape, you must blend research disciplines with scientific intelligence to gain insights. Our services, spanning discovery to submission, along with our committed scientific team, enable you to make program decisions and progress your drug development plan quickly based on high-quality data.
Nonclinical research plays a critical role in every phase of development, from product or drug discovery through IND/CTA programs and onward into late-stage development for NDA/BLA approval. Whichever phase you’re in, we’re ready to help you advance to your next milestone.
?fmt=webp)
Effectively navigate the complexities and intricacies of your therapeutic area and modality—backed by deep experience, tailored solutions and built-for-purpose study facilities. Our informed path to high-quality, regulatory-compliant data accelerates your early drug development program toward success.
Fast forward to our online catalog to find a specific nonclinical assay or study.
We also provide testing for other industries.
With decades of experience, deep scientific capabilities, and a global laboratory network, we’re ready to support your nonclinical development goals. From advances in study technology and commitment to animal welfare—to reimagining processes at the speed of digital pathology and SEND-compliant data formats, we bring you a 360° perspective of your nonclinical development program. Find out more about our investments, rich history and experience.
New approach methods (NAMs) continue to pave the way for more effective human risk assessments for FDA-regulated compounds. To help guide best approaches to these emerging methods, the FDA has released “Potential Approaches to Drive Future Integration of New Alternative Methods for Regulatory Decision-Making,” the latest report detailing recommendations from a NAMs subcommittee of the FDA Science Board.
NOW AVAILABLE
Improve your therapeutic efficacy predictions with our fully characterized patient-derived xenografts (PDX) representing multiple histotypes.
Map your path forward. Download a copy of the drug development journey map to gain a full view of what’s ahead.
When your business goal is to exit, invest or partner on your asset, you can kick-start strategic conversations with the help of MarketPlace. Real connections are made every month. Let the next be yours.
Accelerate your molecule through critical milestones, while maximizing your asset’s value, with our uniquely integrated programmatic approach and dedicated program managers.
Enjoy global support and capacity for your nonclinical and preclinical studies with labs strategically positioned around the world.
To find support for your drug development, browse our scientific publications, posters, webinars and presentations. Our scientists offer decades of experience and share world-class expertise.
